Recombinant human IGFBP-1 protein

Cat No.
ATGP4103

Size

QTY

List Price

10ug

USD 160


20ug

USD 280

50ug

USD 460

100ug

USD 770

250ug

USD 1,340

500ug

USD 2,300

1mg

USD 3,840

USD 0



Product Information

Product Type
Recombinant Protein
Expression System
HEK293
Domain
26-259aa
UniProt No.
P08833
NCBI Accession No.
NP_000587.1
Alternative names
insulin like growth factor binding protein 1, IGFBP1, AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12, IGF-binding protein 1, Placental protein 12, amniotic fluid binding protein, alpha-pregnancy-associated endometrial globulin

Product Specification

Molecular Weight
25.2kDa (234aa)
Concentration
0.5mg/ml (determined by Absorbance at 280nm)
Formulation
Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol
Purity
> 95% by SDS-PAGE
Bioactivity
Measured by its ability to inhibit proliferation using MCF-7 human breast cancer cells in the presence of Human IGF-1. The ED50 range ≤3 ug/ml.
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
Non-Tagged
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain

Biological Activity

Human IGFBP-1 inhibit proliferation using MCF-7 human breast cancer cells in the presence of Human IGF-1. The ED50 range ≤3 ug/ml.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.